Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010
- PMID: 20431523
Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010
Erratum in
- MMWR Morb Mortal Wkly Rep. 2010 May 14;59(18):561
Abstract
The advent of the 2009 influenza A (H1N1) pandemic in April 2009 made the 2009-10 influenza season highly unusual. Public awareness of the potential seriousness of influenza was heightened by media coverage of pandemic-associated hospitalizations and deaths, especially among younger persons. In the fall, the distribution of two separate influenza vaccines began, with distinct, although overlapping, recommendations from the Advisory Committee on Immunization Practices (ACIP). In addition, 2009-10 was the first full season in which ACIP's recommendation to vaccinate all children aged 5--18 years was implemented. To provide preliminary state-specific estimates of seasonal influenza vaccination coverage, CDC analyzed Behavioral Risk Factor Surveillance System (BRFSS) and National 2009 H1N1 Flu Survey (NHFS) data collected during October 2009-February 2010. By January 31, estimated state seasonal influenza vaccination coverage among persons aged >or=6 months ranged from 30.3% to 54.5% (median: 40.6%). Median coverage was 41.2% for children aged 6 months-17 years, 38.3% for adults aged 18--49 years with high-risk conditions, 28.8% for adults aged 18-49 years without high-risk conditions, 45.5% for adults aged 50-64 years, and 69.3% for adults aged >or=65 years. These results, compared with the previous season, suggest large increases in coverage for children and a moderate increase for adults aged 18-49 years without high-risk conditions. Health departments should identify best practices that lead to higher vaccination coverage and should support effective vaccination services (e.g., school-located vaccination programs and office-based protocols, such as reminder/recall and standing orders).
Similar articles
-
Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010.MMWR Morb Mortal Wkly Rep. 2010 Apr 2;59(12):363-8. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20360670
-
Influenza vaccination coverage among children and adults - United States, 2008-09 influenza season.MMWR Morb Mortal Wkly Rep. 2009 Oct 9;58(39):1091-5. MMWR Morb Mortal Wkly Rep. 2009. PMID: 19816396
-
State-specific influenza vaccination coverage among adults aged > or =18 years--United States, 2003-04 and 2005-06 influenza seasons.MMWR Morb Mortal Wkly Rep. 2007 Sep 21;56(37):953-9. MMWR Morb Mortal Wkly Rep. 2007. PMID: 17882124
-
Impact of influenza on young children and the shaping of United States influenza vaccine policy.Pediatr Infect Dis J. 2003 Oct;22(10 Suppl):S231-5. doi: 10.1097/01.inf.0000092194.33331.66. Pediatr Infect Dis J. 2003. PMID: 14551482 Review.
-
The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus.Postgrad Med. 2009 Sep;121(5):43-7. doi: 10.3810/pgm.2009.09.2051. Postgrad Med. 2009. PMID: 19820273 Review.
Cited by
-
Highlights of historical events leading to national surveillance of vaccination coverage in the United States.Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):3-12. doi: 10.1177/00333549111260S202. Public Health Rep. 2011. PMID: 21815302 Free PMC article.
-
Influenza vaccination of parents and guardians by US pediatricians.Hum Vaccin. 2011 Apr;7(4):436-40. doi: 10.4161/hv.7.4.14171. Epub 2011 Apr 1. Hum Vaccin. 2011. PMID: 21445003 Free PMC article.
-
Influenza Vaccine Effectiveness in Mainland China: A Systematic Review and Meta-Analysis.Vaccines (Basel). 2021 Jan 23;9(2):79. doi: 10.3390/vaccines9020079. Vaccines (Basel). 2021. PMID: 33498688 Free PMC article. Review.
-
Tdap Vaccination Among Healthcare Personnel-21 States, 2013.Am J Prev Med. 2018 Jan;54(1):119-123. doi: 10.1016/j.amepre.2017.09.017. Epub 2017 Nov 21. Am J Prev Med. 2018. PMID: 29174081 Free PMC article.
-
Method for screening influenza neutralizing antibodies in crude human plasma and its derivatives using SPR.Heliyon. 2023 Apr 23;9(5):e15651. doi: 10.1016/j.heliyon.2023.e15651. eCollection 2023 May. Heliyon. 2023. PMID: 37144181 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous